Disclaimer

This service is solely for personal and non-commercial use and general information and reference only. This information is strictly prohibited for distributing or made available to any person. The information in this website relating to funds is provided by Morningstar Asia Limited (“Information Provider”) to Chief Securities Limited (the "Company") unless otherwise specified. For technical reasons, certain information provided by Information Provider may be different from that supplied by the respective fund houses. Neither the Information Provider nor the Company guarantee or endorse the accuracy, reliability and completeness of the information provided by the Information Provider or that it is up-to-date, and that such information has not been independently verified by the Company. The Company disclaims liability for any errors, omissions, or inaccuracies in the information provided in this website. The Company also disclaims liability for any loss or damages resulting from the use of the information contained herein, or the inability to use such information or in connection with any error, interruption, delay in operation or incomplete transmission, line or system failure.

For information which is "Powered By" the Information Provider and other fund houses, it is being re-transmitted by the Company in the ordinary course of business to you for general information and reference purposes only.

This service should not be regarded as an offer, solicitation, or recommendation to buy or sell investment products in any jurisdiction to any person to whom it is unlawful to make such an invitation, offer, solicitation or recommendation in such jurisdictions.

The relevant pages for funds have not been reviewed by the Securities and Futures Commission in Hong Kong ("SFC"). The information contained herein is for general information and reference purposes only and is not intended to provide professional investment or other advice. It is not intended to form the basis of any investment decision. Persons accessing this website should not make any investment decision based solely on the information and services provided herein. Before making any investment decision, persons accessing this website should take into account his/her own circumstances including but not limited to his/her financial situation, investment experience, and investment objectives, and should understand the nature, terms and risks of the relevant funds. Persons accessing these pages should obtain appropriate professional advice where necessary.

Investors should note that all investments involve risks (including the possibility of a loss of the capital invested), prices of funds may go up as well as down and past performance information presented is not necessarily a guide to the future performance. Investors should read the relevant fund’s offering documents (including the stated full text of the risk factors) and seek independent financial advice before making any investment decision. Smaller or emerging markets for funds can be more volatile than developed markets and can carry more risk. Independent financial advice should be taken before entering into any financial transaction. The information, contents and/ or features of the webpages are subject to change without notice.

Disclaimer
Important message to readers and internet privacy policy statement
Copyright © 2024 Chief Group Limited. All rights reserved.

Provide Chinese Only.

每月動向

2024年2月基金投資動向

2024年02月05日

中港股市面臨信心不足的困擾,美國減息預期利好美股及美債,資金須考慮謹慎分散的配置策略

2024年首月,香港股市異常波動,與環球股市的表現明顯脫節。儘管外圍股市表現良好,恒生指數卻持續下跌,月內曾經低見14,794點,全月累計下跌1,562點或9.16%,最終收報15,485點。

1月11日,美國公佈最新的消費物價指數(CPI),同比增長3.4%,超出市場預期。市場認為美國CPI未能進一步大幅回落,主要原因是能源價格下降的速度放緩。胡塞組織在紅海的航運襲擊導致商船需要繞道行走,這將增加物流運輸原油成本,不利歐、美壓抑通脹,亦可能令到息率高踞不下。不過,市場分析認為息率上升週期已經結束,並普遍認為美聯儲將在美國大選年內降低利率以刺激經濟。近日美國十年期國庫債券孳息率一度回落至近3.9厘的水平,反映投資者對減息的憧憬。減息有助資金流入新興市場,相關地區股市及債券有望提供更好的資本增值空間。

中港股市近期表現令投資者擔憂,恒生指數於1月22日幾乎跌近2022年10月的低位,隨後因市場傳出內地將會推出兩萬億人民幣平準基金,加上內地推出「連環拳」救市措施,包括2月5日下調存款準備金率0.5個百分點,向市場提供1萬億元的人民幣流動性;並將三農及小微企業的再貸款、再貼現利率從2%下調至1.75%,在利好消息的帶動下,恒指一度重上16,000點大關,但其後受內房債務問題及美國「生物安全法案」的影響,港股再次受壓。藥明康得(2359)和聯想(0992)受中美角力的憂慮拖累,導致科技和醫藥股下跌。

市埸分析,現時投資者普遍對中港經濟表現缺乏信心。中國國家統計局於1月17日公布2023年第四季度和全年GDP增長5.2%,略高於中央原訂5%左右的增長目標,亦高於全球3%左右的預計增長,惟市場似乎仍然對內地經濟可能出現通縮感到憂慮。美國前財長薩默斯近日接受媒體訪問時,表示關注中國經濟存在一些隱憂,包括基建過度投資、民間存款過多、需求疲弱、通縮等問題,可能對中國經濟的穩定和可持續發展造成影響。薩默斯相信中國政府擁有優秀的官僚能力,因此他不認為中國經濟已經無法應對目前的問題,並強調不要過早判斷中國經濟已經不行。

中港股市仍然面臨著信心不足的困擾,但近日大市成交金額有所回升,且有多家公司進行股份回購,對股市短期表現或有一定支持。然而,在內房問題和中美角力的環境下,建議𧫴守分散投資策略,並考慮將資金分散配置投資評級債券基金。投資者除可獲得相對穩定的派息外,還可在美聯儲減息政策進一步落實時,獲得債券價格上升帶來的利潤。

投資者透過基金組合投資,由專業投資經理管理,投資組合可以分佈在不同地區、資產、行業、公司等,有助分散風險。客戶如欲查詢有關基金資訊,歡迎致電致富理財熱線: 2500 9188 聯絡我們。



免責聲明
上述報告由致富證券有限公司(「本公司」)所提供,所載之內容或意見乃根據本公司認為可靠之資料來源來編製,惟本公司並不就此等內容之準確性、完整性及正確性作出明示或默示之保證。上述報告內之所有意見均可在不作另行通知之下作出更改。上述報告的作用純粹為提供資訊,並不應視為對上述報告內提及的任何產品買賣或交易之專業推介、建議、邀請或要約。本公司及其附屬公司、僱員及其家屬及有關人士可於任何時間持有、買賣或以市場認可之方式,包括以代理人或當事人對本報告內提及的任何產品進行投資或買賣。投資附帶風險,投資者需注意投資項目之價值可升亦可跌,而過往之表現亦不一定反映未來之表現。投資者進行投資前請尋求獨立之投資意見。本公司在法律上均不負責任何人因使用本報告內資料而蒙受的任何直接或間接損失。本公司擁有此報告內容之版權,在未獲本公司許可前,不得翻印、分發或發行本報告以作任何用途。

< 返回致富研究
App Download
Instant trading of stocks after taking an in-depth look at every move of the market
Website Push Notifications
Provide the latest financial news and promotions

Subscribe to keep up to date with CHIEF
Informative contents include:
Latest news, coming seminar, featured articles on wealth management